MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
MOGAT3 | Monoacylglycerol O-acyltransferase 3 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
MYO1A | Myosin IA | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
MYRFL | Myelin regulatory factor-like | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NKX6-3 | NK6 homeobox 3 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
OAT | Ornithine aminotransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
RBP2 | Retinol binding protein 2, cellular | Predicted intracellular proteins Transporters
| | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
SCT | Secretin | Predicted secreted proteins
| | | | | Group enriched |
SCTR | Secretin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
SH2D7 | SH2 domain containing 7 | Predicted intracellular proteins
| | | | | Group enriched |
SI | Sucrase-isomaltase (alpha-glucosidase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35G1 | Solute carrier family 35, member G1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC39A4 | Solute carrier family 39 (zinc transporter), member 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
SLC5A4 | Solute carrier family 5 (glucose activated ion channel), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A9 | Solute carrier family 5 (sodium/sugar cotransporter), member 9 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A20 | Solute carrier family 6 (proline IMINO transporter), member 20 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SMLR1 | Small leucine-rich protein 1 | Predicted membrane proteins
| | | | | Group enriched |